Alle Fälle anzeigen
UPC APP 32590/2025
—
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieAkteneinsicht (RoP262)
- Parteien
- Beklagte
- Moderna, Inc.
- Moderna Belgium S.R.L.
- Moderna Denmark ApS
- Moderna Sweden AB
- Moderna Switzerland GmbH
- Moderna Portugal Unipessoal LDA
- ModernaTX, Inc.
- Moderna Norway AS
- Moderna Poland SP. Z.O.O.
- Moderna Netherlands B.V.
- Moderna Biotech UK Limited
- Moderna Italy S.R.L.
- Moderna Germany GmbH
- Moderna France SASU
- Moderna Biotech Spain SL
Vertreter: Ruben Laddé; Joachim Renken - Division
- The Hague LD
- Richter
- —
- Sprache
- —
- Erste Entscheidung
- 4. Aug. 2025
Entscheidungen
- 2025-08-04Application RoP262A
The Local Division The Hague issued a confidentiality order under R.262A RoP based on an agreement reached between Moderna entities and Arbutus Biopharma/Genevant, establishing a confidentiality club for technical information disclosed in infringement proceedings concerning mRNA vaccine patents.
Rechtsfragen:Confidentiality order (R.262A RoP)Confidentiality clubProtection of trade secrets in patent proceedings
Dokumente
- 46231E94C779CBF934A0E5BE534B0AFA_en.pdf2025-08-04EN